Established in 2017, we have been operating as a robotic automation solutions company. In order to diversify our business utilizing MEMS technology, we established a research institute in 2020 and expanded our business category into the bio industry. We developed medical microneedle patches in a Class II GMP-certified medical device manufacturing facility and are currently developing cosmetic microneedle patches as well.
We hold various certifications including ISO 9001, ISO 14001, ISO 22716, and a Class II GMP compliance certificate for medical device manufacturing. We have also been officially recognized for our technological capabilities through designation as a specialized materials, parts, and equipment company and selection for the Regional Specialized Project Legend 50+. In addition, we own eight key microneedle-related patents, including Patent No. 10-2367746 (Manufacturing Method for Transdermal Drug Delivery Microneedle Patches).